Combination of Whole-Body Baseline CT Radiomics and Clinical Parameters to Predict Response and Survival in a Stage-IV Melanoma Cohort Undergoing Immunotherapy
Background: This study investigated whether a machine-learning-based combination of radiomics and clinical parameters was superior to the use of clinical parameters alone in predicting therapy response after three months, and overall survival after six and twelve months, in stage-IV malignant melano...
Main Authors: | Felix Peisen, Annika Hänsch, Alessa Hering, Andreas S. Brendlin, Saif Afat, Konstantin Nikolaou, Sergios Gatidis, Thomas Eigentler, Teresa Amaral, Jan H. Moltz, Ahmed E. Othman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/12/2992 |
Similar Items
-
Can Whole-Body Baseline CT Radiomics Add Information to the Prediction of Best Response, Progression-Free Survival, and Overall Survival of Stage IV Melanoma Patients Receiving First-Line Targeted Therapy: A Retrospective Register Study
by: Felix Peisen, et al.
Published: (2023-10-01) -
Pre-treatment 18F-FDG-PET/CT parameters as biomarkers for progression free survival, best overall response and overall survival in metastatic melanoma patients undergoing first-line immunotherapy.
by: Felix Peisen, et al.
Published: (2024-01-01) -
PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity
by: Yan Gu, et al.
Published: (2023-01-01) -
ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade
by: Damian J. Ralser, et al.
Published: (2023-06-01) -
A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma
by: Wenna Guo, et al.
Published: (2019-06-01)